loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 203214 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 PF PRISM CV (2)

filter

01 TABLET;ORAL (2)

filter

01 RX (2)

filter

01 XELJANZ (2)

filter

01 Yes (2)

URL Supplier Web Content
TABLET; ORAL
EQ 5MG BASE
2012-11-06
203214
XELJANZ
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
EQ 10MG BASE
2018-05-30
203214
XELJANZ
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 203214

Looking for FDA Orange Book APPLICATION 203214 2

19

Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is TOFACITINIB CITRATE, with a corresponding application number 203214.

Regulatory Information RX

With a dosage strength EQ 5MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2012-11-06

18

Pfizer Inc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is TOFACITINIB CITRATE, with a corresponding application number 203214.

Regulatory Information RX

With a dosage strength EQ 10MG BASE

Dosage Form Route TABLET; ORAL

Reference Listed Drug Yes

Approved since 2018-05-30

Post Enquiry
POST ENQUIRY